Health Highlights: May 13, 2010
2.5 Million Step2 Toy Buggies Recalled E. Coli Outbreak Expands to Tennessee Changes Seen in Substance Abuse Treatment Admissions Osteoporosis Screenings Increase DramaticallySwallowing Topical Benadryl Gel Can Be Hazardous: FDA
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
2.5 Million Step2 Toy Buggies Recalled
A problem with handles has led Step2 Co. to recall 2.5 million ride-on toys that pose a "serious risk of injury to young children," the U.S. Consumer Product Safety Commission said Thursday.
Two children needed "professional medical treatment" after the handle detached from the car-like buggies, and 26 children got scraped and scratched in other incidents, the agency said in a statement, Bloomberg reported.
A pin with a yellow head on Step2's "Push Around and Whisper Ride" buggies can come loose, enabling the buggy to roll way, the agency said.
The recall applies to buggies sold from August 1999 through March 2010 for $29 to $59, the CPSC said.
Consumers are advised to stop using the buggies and contact Step2 for a free repair kit, by calling 1-866-860-1887 or visiting the company's website, www.step2.com, the agency said.
E. Coli Outbreak Expands to Tennessee
An E. coli outbreak linked to romaine lettuce grown in Arizona has expanded, said federal officials who reported on Wednesday that another person became ill in Tennessee.
The Centers for Disease Control and Prevention said it knows of 23 confirmed cases and seven probable cases, but because this is a rare and hard-to-detect strain, there may be other unreported cases, the Associated Press reported.
Earlier this week, the CDC reported 19 cases, all confined to Michigan, Ohio and New York. All were stricken before late April, and many were students who ate in school cafeterias, the AP reported.
So far, two recalls of romaine lettuce have been announced by distributors who bought lettuce from the same as-yet-unidentified Yuma, Ariz., farm. Vaughn Foods of Moore, Okla., publicized a recall of romaine lettuce Monday, and last week Freshway Foods of Ohio announced a 23-state recall.
The recalled lettuce was primarily sold to food service establishments. Bagged lettuce in grocery stores was not included in the recalls, the AP said.
Because the lettuce passed through several facilities before being eaten, the Food and Drug Administration is still trying to determine precisely where the contamination occurred. Suppliers buy bulk lettuce directly from farms and sell it to distributors, which then sell it to food service establishments or retail customers, the AP said.
Changes Seen in Substance Abuse Treatment Admissions
Patterns of substance abuse treatment in the United States have changed over the past decade, with a larger percentage of people 12 and older now treated for drug use alone, a new U.S. report shows.
Treatment admissions attributed to drug abuse alone rose from 26 percent in 1998 to 37 percent in 2008, says a study released Wednesday by the Substance Abuse and Mental Health Services Administration (SAMHSA). The study also found that admissions involving alcohol abuse alone dropped from 27 percent in 1998 to 23 percent in 2008.
The percentage of patients treated for co-abusing drugs and alcohol declined gradually -- from 44 percent to 38 percent -- during the 10-year period, the report noted.
Other trends noted in the study:
- Five substances were involved in 96 percent of treatment admissions: alcohol, marijuana, opiates, cocaine and stimulants (mainly methamphetamine).
- Opiate admissions increased from 16 percent of admissions in 1998 to 20 percent in 2008.
- Cocaine admissions decreased from 15 percent in 1998 to 11 percent in 2008.
- Admissions for marijuana use rose from 13 percent in 1998 to 17 percent in 2008.
- Stimulant admissions grew from 4 percent in 1998 to 6 percent in 2008.
- Marijuana was a primary or secondary substance in 79 percent of adolescent treatment admissions.
"This survey provides valuable insight into the changing nature and source of substance abuse treatment admissions," SAMHSA Administrator Pamela S. Hyde said in a news release. The findings can help lead to more effective treatment programs, she said.
Osteoporosis Screenings Increase Dramatically
More women age 65 and older on Medicare are getting recommended osteoporosis screenings, says a new U.S. report that found the number who had bone density or bone mass screenings nearly doubled over a recent five-year period.
In 2006, 64 percent of women in that population said they had been screened for osteoporosis compared with 34 percent in 2001, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The agency also found that:
- The percentage of white women who reported osteoporosis screening jumped from 36 percent to 67 percent during those years.
- Hispanic women reported a dramatic increase in screening, from 22 percent to 55 percent.
- The number of black women who said they were screened also rose significantly -- from 16 percent to 38 percent.
- Income seems to have an effect on screening rates. Just 46 percent of low-income women reported being screened by 2006, compared with 80 percent of high-income women.
The U.S. Preventive Services Task Force advises women age 65 and older to undergo routine osteoporosis screening. Women are more likely than men to develop the disabling disease, which can lead to fractured bones, limited mobility and even death.
Swallowing Topical Benadryl Gel Can Be Hazardous: FDA
Consumers who mistakenly swallow Benadryl Extra Strength Itch Stopping Gel, an over-the-counter product for use on the skin, could suffer serious side effects, the U.S. Food and Drug Administration warned Wednesday.
Swallowing the gel can expose people to a dangerous amount of the active ingredient, diphenhydramine, which can cause unconsciousness, hallucinations, and confusion, the agency said.
Some Benadryl products are meant to be swallowed, which may explain why some people erroneously ingest the gel, experts said.
"Consumer confusion and incorrect product use are serious public health issues," Carol Holquist, director of the FDA's Division of Medication Error Prevention and Analysis, said in a news release. "FDA is advising consumers and pharmacies to store products for the skin separately from products that should be swallowed."
The gel's manufacturer, Johnson & Johnson, has repackaged the product, adding the statement "For Skin Use Only" to the label of packages now in stores, the FDA said.